Intravascular Ultrasound Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Intravascular Ultrasound Market Summary
Introduction
Intravascular ultrasound (IVUS) systems, including virtual histology, iMAP, and integrated backscatter types, guide minimally invasive cardiovascular interventions (3 million PCI procedures annually). IVUS enhances stent placement accuracy and reduces complications. The market is driven by rising cardiovascular diseases (17.9 million deaths), aging populations (2.1 billion over 60 by 2050), and demand for precise diagnostics. Innovations like high-resolution imaging and AI integration boost adoption. The global market is projected to reach between USD 510 million and USD 790 million in 2025, with a CAGR of 4.2% to 6.1% through 2030.

Regional Analysis
North America: The U.S. leads with high PCI volumes, while Canada focuses on coronary care.
Europe: Germany, France, and the UK drive demand due to advanced cardiology systems.
Asia Pacific: China sees growth from rising CVD cases, while Japan emphasizes elderly care.
Rest of the World: Brazil expands cardiac services, and the Middle East invests in diagnostics.

Application Analysis
Hospitals: Expected growth of 4.3%-6.2%, driven by PCI procedures. Trends focus on real-time imaging.
Diagnostic Imaging Centers: Projected growth of 4.2%-6.1%, linked to outpatient diagnostics. Developments emphasize portability.
Academic and Research Institutes: Anticipated growth of 4.4%-6.3%, suited for innovation. Advances prioritize AI integration.

Type Analysis
Virtual Histology IVUS: Expected growth of 4.4%-6.3%, valued for tissue characterization. Trends highlight 3D visualization.
iMAP IVUS: Projected growth of 4.3%-6.2%, key for plaque assessment. Advances focus on precision.
Integrated Backscatter IVUS: Anticipated growth of 4.2%-6.1%, driven by detailed imaging. Innovations emphasize automation.

Key Market Players
Leading firms include Philips, offering Proxis; Boston Scientific Corporation, enhancing IVUS; Canon Medical Systems Corporation, scaling diagnostics; Siemens Healthcare, focusing on imaging; GE Healthcare, boosting precision; Hitachi, advancing ultrasound; Mindray Medical International, targeting affordability; Samsung Medison, innovating in imaging; Chison Medical Technologies, scaling solutions; and Fujifilm, supporting diagnostics.

Porter's Five Forces Analysis
Threat of New Entrants: Moderate, due to high R&D and regulatory barriers, though AI innovators can enter.
Threat of Substitutes: Low, as IVUS is essential for precise PCI with no direct alternatives.
Bargaining Power of Buyers: Moderate, with facilities seeking accurate, cost-effective systems, though clinical needs limit options.
Bargaining Power of Suppliers: Low, with multiple component providers.
Competitive Rivalry: High, with competition on imaging resolution, AI integration, and cost.

Market Opportunities and Challenges
Opportunities:
Cardiovascular diseases (17.9 million deaths) and PCI procedures (3 million annually) drive demand.
Aging populations (2.1 billion over 60 by 2050) boost needs, while high-resolution imaging and AI enhance adoption.
Minimally invasive trends increase usage.
Challenges:
High costs of advanced IVUS systems limit access in low-income regions.
Regulatory delays for AI tech slow growth.
Limited interventional cardiologists in rural areas restrict expansion.

Market News
In April 2024, Provisio Medical’s Provisio IVUS System received FDA clearance for real-time measurements.
In May 2024, SonoVascular partnered with Lantheus Holdings for the SonoThrombectomy System.
In October 2023, Evident Vascular launched with USD 35 million for AI-enhanced IVUS technology. Show more